Skip to main content
. 2018 Aug 8;9:3164. doi: 10.1038/s41467-018-05550-5

Fig. 4.

Fig. 4

Decitabine treatment decreases the expression and the CGI methylation levels of genes hypermethylated and overexpressed in Alb-R26Met tumours. Expression and CGI methylation levels of a set of genes found hypermethylated and overexpressed in the Alb-R26Met tumours were analysed in dissected tumours from Alb-R26Met mice either untreated (red) or treated with Decitabine (green). For each indicated gene, graphs report the methylation levels of CpGs within the CGI of interest (left) and the expression levels of genes (right) in tumours from Alb-R26Met mice either untreated (red) or treated with Decitabine (green), compared to control livers (blue). Note that demethylating treatment significantly decreased transcription levels. Concerning the Scn8a gene, the methylation levels of its gene body CGI was reduced in Decitabine treated tumours compared to untreated tumours. This was accompanied by a trend in downregulation of its expression levels, although not significant. It is possible that for Scn8a, the demethylation extent caused by the dose of Decitabine used is suboptimal to significantly influence its expression levels. Alternatively, a more complex mechanism could be involved in the regulation of Scn8a expression. Significance is indicated on the top. Not significant (ns): P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001